Cover [Abstract] Entity Central Index Key Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Entity Listing, Par Value Per Share Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Statement of Financial Position [Abstract] Assets [Abstract] Assets, Current [Abstract] Current assets: Cash and Cash Equivalent Cash and cash equivalents Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable, net Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Property and equipment, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Intangible Asset, Finite-Lived, after Accumulated Amortization Intangible assets, net Deferred Income Tax Assets, Net Deferred tax assets Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable This element represents the carrying value as of the balance sheet date of obligations incurred and payable, pertaining to research and development costs, that are statutory in nature, which are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research and Development Expense, Current Accrued research and development costs Carrying value as of the balance sheet date of accrued expenses and as well as used to reflect the other current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Expenses and Other Liabilities, Current Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Operating Lease, Liability, Current Less: current portion of operating lease liabilities Current portion of operating lease liabilities Convertible Debt, Current Current portion of convertible senior notes Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Operating lease obligations, net of current portion Operating lease liabilities, net of current portion Long-Term Line of Credit, Noncurrent Revolving credit facility Other Liabilities, Noncurrent Other liabilities Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies Equity, Attributable to Parent [Abstract] Stockholders' deficit: Common Stock, Value, Issued Class A Common Stock, $0.001 par value, 500,000,000 shares authorized; 165,239,947 shares issued and outstanding as of June 30, 2026 and 163,058,316 shares issued and outstanding as of December 31, 2025 Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Equity, Attributable to Parent Total stockholders' deficit Liabilities and Equity Total liabilities and stockholders' deficit Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Preferred Stock Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Common Stock Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares, Issued Balance (in shares) Balance (in shares) Common stock, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Income Statement [Abstract] Statement [Table] Statement [Line Items] Operating Income (Loss) [Abstract] Revenues [Abstract] Revenues: Revenue from Contract with Customer, Excluding Assessed Tax Revenue Total revenues Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Revenue from Contract with Customer, Product and Service Costs and Expenses [Abstract] Costs and expenses: Research and Development Expense Research and development Research and development expense Selling, General and Administrative Expense Selling, general and administrative Restructuring Expense (Benefit) Restructuring Expense (Benefit) Restructuring, net Costs and Expenses Total costs and expenses Operating Income (Loss) Income from operations Nonoperating Income (Expense) [Abstract] Other income (expense): Interest Expense, Nonoperating Interest expense and other financing costs Investment Income, Net Interest and investment income Other Nonoperating Income (Expense) Other Nonoperating Income (Expense) Other income (expense), net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income before income taxes Income Tax Expense (Benefit) Income tax expense Income tax (benefit) expense Net income (loss) Net income (loss) Earnings Per Share, Basic Net income (loss) per share - basic (in dollars per share) Earnings Per Share, Diluted Net income (loss) per share - diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average shares used in computing net income (loss) per share - basic (in shares) Weighted average number of common shares outstanding used in computing net income (loss) per share - basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average shares used in computing net income (loss) per share - diluted (in shares) Weighted average number of common shares outstanding used in computing net income (loss) per share - diluted (in shares) Statement of Comprehensive Income [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Net income Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Currency translation adjustment Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive income (loss), net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Component [Domain] Parent [Member] Parent Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional paid-in capital Retained Earnings [Member] Accumulated deficit AOCI Attributable to Parent [Member] Accumulated other comprehensive income (loss) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Deficit Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Issuance of common stock related to share-based awards and employee stock purchase plan Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Issuance of common stock related to share-based awards and employee stock purchase plan (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Share-based compensation expense related to share-based awards and employee stock purchase plan Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income (loss) Net income (loss) Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss), net of tax Statement of Cash Flows [Abstract] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation Depreciation and amortization Gain (Loss) on Disposition of Property Plant Equipment Loss on disposal of property and equipment Share-Based Payment Arrangement, Noncash Expense Share-based compensation expense Paid-in-Kind Interest Non-cash interest expense Operating Lease, Right-of-Use Asset, Periodic Reduction Non-cash lease expense Deferred Income Taxes and Tax Credits Deferred income taxes Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable, net Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses This element represents the net change in research and development expenses, which are accrued during the period, but not yet paid. Increase (Decrease) in Accrued Research and Development Expense Accrued research and development costs Increase (Decrease) in Operating Lease Liability Operating lease liabilities Increase (Decrease) in Other Current Liabilities Other liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash provided by operating activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities: Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Proceeds from employee stock purchase plan Repayments of Convertible Debt Repayment of 2026 Convertible Notes Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Effect of exchange rate changes on cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Organization, Consolidation and Presentation of Financial Statements [Abstract] Disclosure Text Block [Abstract] Disclosure Text Block Nature of Operations [Text Block] Nature of Business Accounting Policies [Abstract] Basis of Presentation and Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Earnings Per Share [Abstract] Earnings Per Share [Text Block] Net Loss Per Share Collaboration and License Agreements Disclosure [Abstract] Collaboration and License Agreements Disclosure [Abstract] Collaborative Arrangement Disclosure [Text Block] Collaboration, License, and Other Agreements Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value of Financial Instruments Leases [Abstract] Lessee, Operating Leases [Text Block] Leases Payables and Accruals [Abstract] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses and Other Current Liabilities Debt Disclosure [Abstract] Debt Disclosure [Text Block] Debt Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Text Block] Employee Stock Benefit Plans Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Restructuring and Related Activities [Abstract] Restructuring and Related Activities Disclosure [Text Block] Workforce Reduction and Restructuring Segment Reporting [Abstract] Segment Reporting [Text Block] Segment Reporting Policy Text Block [Abstract] Policy Text Blocks Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Consolidation, Policy [Policy Text Block] Principles of Consolidation Use of Estimates, Policy [Policy Text Block] Use of Estimates New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Pronouncements Table Text Block [Abstract] Table Text Blocks Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net loss per common share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive securities that have been excluded from computation of diluted weighted average shares outstanding Collaborative Arrangement and Arrangement Other than Collaborative [Table] Counterparty Name [Axis] Counterparty Name [Domain] AbbVie Plc [Member] AbbVie Plc [Member] AbbVie Plc Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaboration, License, Promotion and Other Commercial Agreements Disaggregation of Revenue [Table Text Block] Schedule of revenue attributable to transactions from collaboration and license arrangements Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of assets and liabilities measured at fair value on a recurring basis Lease, Cost [Table Text Block] Schedule of components of lease cost and supplemental cash flow information Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of future minimum lease payments under non-cancelable operating leases Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Schedule of Long-Term Debt Instruments [Table] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Domain] Secured Debt [Member] Secured Debt Convertible Notes Payable [Member] Convertible Senior Notes Debt Instrument [Line Items] Debt Tabular disclosure of interest expense related to debt. Interest Expense, Debt [Table Text Block] Schedule of interest expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Share-based compensation expense reflected in the condensed consolidated statements of operations Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update [Axis] Accounting Standards Update [Domain] Accounting Standards Update 2024-03 [Member] Accounting Standards Update 2024-03 Accounting Standards Update 2024-04 [Member] Accounting Standards Update 2024-04 Accounting Standards Update 2025-05 [Member] Accounting Standards Update 2025-05 Accounting Standards Update 2025-06 [Member] Accounting Standards Update 2025-06 Accounting Standards Update 2025-07 [Member] Accounting Standards Update 2025-07 New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Change in Accounting Principle, Accounting Standards Update, Adopted Change in Accounting Principle, Accounting Standards Update, Adoption Date Change in Accounting Principle, Accounting Standards Update, Adoption Date Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) Time-based Restricted Stock Units [Member] Time-based Restricted Stock Units [Member] Time-based Restricted Stock Units Performance-based Restricted Stock Units [Member] Performance-based Restricted Stock Units [Member] Performance-based Restricted Stock Units Restricted Stock [Member] Restricted Stock Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Numerator: Net Income (Loss) Available to Common Stockholders, Basic Numerator used in computing net income per share - basic Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities Add back interest expense, net of tax benefit, on assumed conversion of 2026 Convertible Notes Net Income (Loss) Available to Common Stockholders, Diluted Numerator used in computing net income per share - diluted Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted Average Number of Shares Outstanding, Basic [Abstract] Denominator: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] Effect of dilutive securities: Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Effect of dilutive securities, share-based compensation Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 2026 Convertible Notes assumed conversion Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Convertible Debt Securities [Member] 1.50% Convertible Senior Notes, Due 2026 [Member] Convertible Senior Notes, 1.50 Percent, Due 2026 [Member] 1.50% Convertible Senior Notes due 2026 Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Earnings Per Share, Diluted [Abstract] Potentially dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total potentially dilutive securities excluded from the computation of diluted weighted average shares outstanding (in shares) Disaggregation of Revenue [Table] Grand Life Sciences [Member] Grand Life Sciences [Member] Grand Life Sciences Astellas Pharma Inc. [Member] Astellas Pharma Inc [Member] Astellas Pharma Inc. Asahi Kasei Pharma Corporation [Member] Asahi Kasei Pharma Corporation [Member] Asahi Kasei Pharma Corporation Geographical [Axis] Geographical [Domain] North America [Member] North America Europe and Other [Member] Europe and Other [Member] Europe and Other Product and Service [Axis] Product and Service [Domain] Collaborative Arrangements and Active Pharmaceutical Ingredient [Member] Collaborative Arrangements and Active Pharmaceutical Ingredient [Member] Collaborative arrangements and active pharmaceutical ingredient Collaborative Arrangements [Member] Collaborative Arrangements [Member] Collaborative arrangements revenue Collaborative Arrangement, Collaboration and License Agreements [Member] Collaborative Arrangement, Collaboration and License Agreements [Member] Collaborative arrangement, collaboration and license agreements Collaborative Arrangement, Co-promotion and Other Agreements [Member] Collaborative Arrangement, Co-promotion and Other Agreements [Member] Collaborative arrangement, co-promotion and other agreements Royalty [Member] Royalty Collaborative Arrangement, Development and Commercialization Agreements [Member] Collaborative Arrangement, Development and Commercialization Agreements [Member] Collaborative arrangement, development and commercialization agreements Collaborative Arrangement, Other Agreements [Member] Collaborative Arrangement, Other Agreements [Member] Collaborative arrangement, other agreements Disaggregation of Revenue [Line Items] Revenue from Contract with Customer, Excluding Assessed Tax, Net Revenue from Contract with Customer, Excluding Assessed Tax, Net Revenue, net Accounts and Financing Receivables [Table] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts Receivable, after Allowance for Credit Loss [Abstract] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss Accounts receivable, net Accounts Receivable, Net of Accounts Payable, Current and Noncurrent Accounts Receivable, Net of Accounts Payable, Current and Noncurrent Accounts receivable, net of accounts payable Accounts Payable Accounts payable Number of Remaining Commercial Period Performance Obligations. Number of Remaining Commercial Period Performance Obligations Remaining commercial-period performance obligations Represents the reduction to research and development expense for the amount received from the collaboration partner under cost sharing provisions. Cost Sharing Arrangement, Reduction to Research and Development Expense Cost sharing amount, reduction to research and development Collaborative Arrangement, Percentage of Obligation of Development Costs Incurred Collaborative Arrangement, Percentage of Obligation of Development Costs Incurred Collaborative arrangement, percentage of obligation of development costs incurred Represents the percentage of net profit from commercialization. Collaborative Arrangement Percentage of Net Profit Percentage of net profit from commercialization (as a percent) Represents the percentage of net loss from commercialization. Collaborative Arrangement, Percentage of Net Loss Percentage of net loss from commercialization (as a percent) Revenue from Contract with Customer, Excluding Assessed Tax, Reduction Revenue from Contract with Customer, Excluding Assessed Tax, Reduction Revenue, reduction Collaborative Arrangements, LINZESS [Member] Collaborative Arrangements, LINZESS [Member] Collaborative arrangements, LINZESS UNITED STATES U.S. Canada and Mexico [Member] Canada and Mexico [Member] Canada and Mexico License [Member] License Represents the amount of milestone payment to be received by the company upon amendment to the license agreement. Remaining Milestone Payment to be Received by Company upon Amendment to License Agreement Remaining milestone payment due upon the amendment to the license agreement Period over Which Annual Royalty Will Be Paid as Percentage on Net Sales Period over Which Annual Royalty Will Be Paid as Percentage on Net Sales Annual royalty Astellas Pharma Inc., 2009 License Agreement, Amended 2019 [Member] Astellas Pharma Inc, 2009 License Agreement, Amended 2019 [Member] Astellas Pharma Inc., 2009 License Agreement, Amended 2019 Collaborative Arrangement, Royalty Percentage, Aggregate Annual Net Product Sales, Maximum Collaborative Arrangement, Royalty Percentage, Aggregate Annual Net Product Sales, Maximum Collaborative arrangement, royalty percentage, aggregate annual net product sales, maximum (as a percent) Represents the amount to be received by the company upon completion of milestone. Milestone Payment to be Received by Company upon Milestone Achievement Milestone payment to be received by company upon milestone achievement Contract with Customer, Liability, Current Deferred revenue, current Deferred revenue Contract with Customer, Liability, Noncurrent Deferred revenue, noncurrent Contract with Customer, Liability Deferred revenue Collaborative Arrangement, Upfront Payment Received Collaborative Arrangement, Upfront Payment Received Collaborative arrangement, upfront payment received Collaborative Arrangement, Development Related Payment, Eligible to Receive Collaborative Arrangement, Development Related Payment, Eligible to Receive Collaborative arrangement, development related payment, eligible to receive Collaborative Arrangement, Development Related Payment, Received Collaborative Arrangement, Development Related Payment, Received Collaborative arrangement, development related payment, received Collaborative Arrangement, Development Milestones, Eligible to Receive Collaborative Arrangement, Development Milestones, Eligible to Receive Collaborative arrangement, development milestones, eligible to receive Collaborative Arrangement, Development Milestones, Received Collaborative Arrangement, Development Milestones, Received Collaborative arrangement, development milestones, received Collaborative Arrangement, Commercial and Sales-based Milestone Payments, Eligible to Receive Collaborative Arrangement, Commercial and Sales-based Milestone Payments, Eligible to Receive Collaborative arrangement, commercial and sales-based milestone payments, eligible to receive Collaborative Arrangement, Performance Obligations, Number Collaborative Arrangement, Performance Obligations, Number Collaborative arrangement, performance obligations, number Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Domain] Ferring International Center S.A. Complaint Against VectivBio AG, Ferring Settlement Agreement with Entity [Member] Ferring International Center SA Complaint Against VectivBio AG, Ferring Settlement Agreement with Entity [Member] Ferring International Center S.A. Complaint Against VectivBio AG, Ferring Settlement Agreement with Entity Loss Contingencies [Line Items] Loss Contingency, Settlement [Abstract] Loss Contingency, Settlement Litigation Settlement [Abstract] Litigation Settlement Litigation Settlement, Amount Awarded to Other Party Litigation settlement, amount awarded to other party Payments for Legal Settlements Payments for legal settlements Estimated Litigation Liability Estimated litigation liability Estimated Litigation Liability, Current Accrued litigation settlement Gain (Loss) from Litigation Settlement [Abstract] Gain (Loss) from Litigation Settlement Litigation Settlement, Loss Litigation settlement, loss, recorded in selling, general, and administrative expense Fair Value Measurement Inputs and Valuation Techniques [Abstract] Fair Value of Financial Instruments The percentage of threshold collateralized value. Threshold Percentage of Collateralized Value Threshold percentage of collateralized value (as a percent) Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring basis Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash Equivalents [Member] Money Market Funds [Member] Money market funds US Treasury Securities [Member] U.S. Treasury securities Commercial Paper [Member] Commercial paper Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets, Fair Value Disclosure [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash and cash equivalents Assets, Fair Value Disclosure Total assets measured at fair value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Adjustment Disclosure [Abstract] Fair Value Disclosures Long-Term Debt, Fair Value Estimated fair value Lessee, Lease, Description [Table] Summer Street Lease and Vehicle Lease [Member] Summer Street Lease and Vehicle Lease [Member] Summer Street Lease and Vehicle Lease Lessee, Lease, Description [Line Items] Leases Letters of Credit Outstanding, Amount Letters of credit outstanding, amount Lease, Cost [Abstract] Lease Cost Operating Lease, Cost Operating lease cost Short-Term Lease, Cost Short-term lease cost Lease, Cost Total lease cost Lessee Disclosure [Abstract] Operating Leases Operating Lease, Payments Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term of operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate of operating leases (as a percent) Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Domain] Land and Building [Member] Building and Building Improvements [Member] Summer Street Lease [Member] Summer Street Lease [Member] Summer Street Lease Lessee, Operating Lease, Description [Abstract] Operating Leases Area of Real Estate Property Rentable area leased (in square feet) Annual rent escalation in initial lease period and in renewal period. Percentage of Increase in Operating Lease Rent Annual rent escalation (as a percent) Lessee, Operating Lease, Existence of Option to Extend [true false] Option to extend the term of the lease Lessee, Operating Lease, Renewal Term Operating lease, renewal term Operating Lease, Liability Operating lease liabilities Operating lease liability Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (remainder of fiscal year) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four 2030 Lessee, Operating Lease, Liability, to be Paid Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid, Gross Difference [Abstract] Operating lease obligations Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: present value adjustment Accrued Liabilities and Other Liabilities [Abstract] Accrued Expenses Employee-related Liabilities, Current Accrued compensation and benefits Accrued Income Taxes, Current Accrued taxes Interest Payable, Current Accrued interest Restructuring Reserve, Current Accrued restructuring liabilities Other Accrued Liabilities, Current Other Other Accrued Liabilities, Current, Uninvoiced Vendor Liabilities Other Accrued Liabilities, Current, Uninvoiced Vendor Liabilities Other accrued liabilities, uninvoiced vendor liabilities 0.75% Convertible Senior Notes, Due 2024 and 1.50% Convertible Senior Notes, Due 2026 [Member] Convertible Senior Notes, 0.75 Percent, Due 2024 and Convertible Senior Notes, 1.50 Percent, Due 2026 [Member] 0.75% Convertible Senior Notes due 2024 and 1.50% Convertible Senior Notes due 2026 Revolving Credit Agreement [Member] Revolving Credit Agreement [Member] Revolving Credit Agreement Secured Revolving Credit Facility [Member] Secured Revolving Credit Facility [Member] Secured Revolving Credit Facility Letter of Credit Subfacility [Member] Letter of Credit Subfacility [Member] Letter of Credit Subfacility Variable Rate [Axis] Variable Rate [Domain] Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate (SOFR), Adjusted Term Secured [Member] Secured Overnight Financing Rate (SOFR), Adjusted Term Secured [Member] Secured Overnight Financing Rate (SOFR), Adjusted Term Secured Secured Overnight Financing Rate (SOFR), One-month Adjusted Term [Member] Secured Overnight Financing Rate (SOFR), One-month Adjusted Term [Member] Secured Overnight Financing Rate (SOFR), One-month Adjusted Term Fed Funds Effective Rate Overnight Index Swap Rate [Member] Fed Funds Effective Rate Overnight Index Swap Rate Applicable Rate [Member] Applicable Rate [Member] Applicable Rate Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Debt Instrument, Interest Rate, Stated Percentage Debt instrument, interest rate, stated percentage (as a percent) Line of Credit Facility, Maximum Borrowing Capacity Line of credit facility, maximum borrowing capacity Debt Instrument, Face Amount Debt instrument, face amount Debt Instrument, Basis Spread on Variable Rate Debt instrument, basis spread on variable rate (as a percent) Line of Credit Facility, Frequency of Commitment Fee Payment Line of credit facility, frequency of commitment fee payment Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Line of credit facility, unused capacity, commitment fee percentage (as a percent) The maximum percentage of capital stock of foreign subsidiaries pledged under credit agreement. Line of Credit Facility, Pledge of Foreign Subsidiaries Capital Stock, Maximum, Percent Percentage of capital stock of foreign subsidiaries pledged (as a percent) Line of Credit, Additional Borrowing Capacity through Accordion Feature Line of Credit, Additional Borrowing Capacity through Accordion Feature Additional borrowing capacity The additional borrowing capacity under line of credit, as percentage of consolidated adjusted earnings before interest tax depreciation and amortization. Line of Credit Facility, Additional Borrowing Capacity, Percent of Consolidated Adjusted Earnings Before Interest Tax Depreciation and Amortization Additional borrowing capacity, percentage (as a percent) The trailing period considered for calculation of consolidated adjusted earnings before interest, tax, depreciation and amortization. Line of Credit Facility, Additional Borrowing Capacity, Trailing Period for Consolidated Adjusted Earnings Before Interest, Tax, Depreciation and Amortization Calculation Additional borrowing capacity, trailing period Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, after Interim Period Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, after Interim Period Debt instrument, covenant, maximum consolidated secured net leverage ratio, after interim period Debt Instrument, Covenant, Minimum Interest Coverage Ratio Debt Instrument, Covenant, Minimum Interest Coverage Ratio Debt instrument, covenant, minimum interest coverage ratio Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, after Interim Period, Consummates Acquisition, after Elected Increase Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, after Interim Period, Consummates Acquisition, after Elected Increase Debt instrument, covenant, maximum consolidated secured net leverage ratio, after interim period, consummates acquisition, after elected increase Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, Consummates Acquisition, Number of Fiscal Quarters Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, Consummates Acquisition, Number of Fiscal Quarters Debt instrument, covenant, maximum consolidated secured net leverage ratio, consummates acquisition, number of fiscal quarters Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, Consummates Acquisition, Minimum Consideration Debt Instrument, Covenant, Maximum Consolidated Secured Net Leverage Ratio, Consummates Acquisition, Minimum Consideration Debt instrument, covenant, maximum consolidated secured net leverage ratio, consummates acquisition, minimum consideration Proceeds from Issuance of Long-Term Debt Net proceed received Debt Instrument, Fee Amount Fees and expenses Payments for Hedge, Financing Activities Payments for convertible note hedges Debt Instrument, Repurchased Face Amount Debt redeemed/repurchased Debt Instrument, Interest Rate, Effective Percentage Effective interest rate on liability components (as a percent) Debt Issuance Costs, Gross, Incurred during Period Debt Issuance Costs, Gross, Incurred during Period Debt issuance costs, gross, incurred during period Debt Issuance Costs, Net Debt issuance costs, net Long-Term Debt, Unclassified [Abstract] Principal: Unamortized Debt Issuance Expense Unamortized debt issuance costs Long-Term Debt Net carrying amount Interest Expense, Debt [Abstract] Interest Expense Interest Expense, Debt, Excluding Amortization Contractual interest expense Amortization of Debt Issuance Costs Amortization of debt issuance costs Other Financing Costs Other Financing Costs Other financing costs Interest Expense, Debt Total interest expense Option Indexed to Issuer's Equity, Equity [Table] Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Call Option [Member] Call Option Option Indexed to Issuer's Equity [Line Items] Capped Calls The amount of payment made to counterparties to enter in to capped calls. Payment Made for Investing in Capped Calls Payment made to enter into Capped Calls Payment Made for Investing in Capped Calls, Premium Payment Made for Investing in Capped Calls, Premium Payment made to enter into Capped Calls, premium Payment Made for Investing in Capped Calls, Transaction Cost Payment Made for Investing in Capped Calls, Transaction Cost Payment made to enter into Capped Calls, transaction cost Option Indexed to Issuer's Equity, Strike Price Strike price (in dollars per share) Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Location, Statement of Income, Balance [Axis] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Additional Disclosure [Abstract] Employee Stock Benefit Plans Share-Based Payment Arrangement, Expense Total share-based compensation expense included in operating expenses Share-Based Payment Arrangement, Expense, Tax Benefit Income tax expense (benefit) Share-Based Payment Arrangement, Expense, after Tax Total share-based compensation expense, net of tax Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract] Income Taxes Restructuring Cost [Table] Restructuring Plan [Axis] Restructuring Plan [Domain] Reduction in Company-wide Workforce, January 2025 [Member] Reduction in Company-wide Workforce, January 2025 [Member] Reduction in Company-wide Workforce, January 2025 Restructuring Cost and Reserve [Line Items] Restructuring and Related Cost, Positions Eliminated [Abstract] Workforce Reduction Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Restructuring and related cost, number of positions eliminated, period percent (as a percent) Restructuring, Settlement and Impairment Provisions [Abstract] Restructuring Charges [Abstract] Restructuring Expenses Segment Reporting, Descriptive Information [Abstract] Segment Reporting Number of Reportable Segments Number of reportable segments Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name